Anti-Inflammatory, Immuno-Modulatory and Angiostatic Treatment As Third-Line Therapy for Multiple Myeloma (MM) - a Combined Treatment Setting of Lenalidomide with Pioglitazone, Dexamethasone and Low-Dose Treosulfan (phase I/II)

Reichle, Albrecht and Hart, Chtistina and Grube, Matthias and Andreesen, Reinhard (2012) Anti-Inflammatory, Immuno-Modulatory and Angiostatic Treatment As Third-Line Therapy for Multiple Myeloma (MM) - a Combined Treatment Setting of Lenalidomide with Pioglitazone, Dexamethasone and Low-Dose Treosulfan (phase I/II). BLOOD, 120 (21): 5029. ISSN 0006-4971, 1528-0020

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 26 May 2020 06:12
Last Modified: 26 May 2020 06:12
URI: https://pred.uni-regensburg.de/id/eprint/17795

Actions (login required)

View Item View Item